Ikena Oncology (NASDAQ:IKNA – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Tuesday, Zacks.com reports. They presently have a $7.00 target price on the stock. Zacks Investment Research‘s price objective would indicate a potential upside of 25.67% from the company’s previous […]
Zacks Investment Research upgraded shares of Ikena Oncology (NASDAQ:IKNA – Get Rating) from a hold rating to a buy rating in a research report sent to investors on Wednesday, Zacks.com reports. They currently have $7.50 target price on the stock. According to Zacks, “Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling […]
Zacks Investment Research upgraded shares of Ikena Oncology (NASDAQ:IKNA – Get Rating) from a hold rating to a buy rating in a research note published on Wednesday, Zacks.com reports. They currently have $8.00 price target on the stock. According to Zacks, “Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which […]
Ikena Oncology (NASDAQ:IKNA – Get Rating) issued its earnings results on Thursday. The company reported $0.07 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.51) by $0.58, MarketWatch Earnings reports. NASDAQ IKNA opened at $8.01 on Friday. The firm’s 50 day moving average price is $8.82 and its 200-day moving average price is […]